Fluorouracil, Kombinationen

Generic name
Fluorouracil, Kombinationen
Brand name
ATC Code
L01BC52

Fluorouracil, Kombinationen

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Warts
  • Cutaneous
    • 1 year up to 18 years
      • Apply 2-3 times daily to the wart; remove any film that has formed before reapplying
        Duration of treatment: about 6 weeks, but continue treatment 1 week after symptoms have resolved. 

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

Young children have an increased risk of salicylic acid poisoning if the maximum recommended treatment area (25 cm2) or treatment frequency is significantly exceeded [SmPC Verrumal].

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIMETABOLITES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Purine analogues
L01BB06
L01BB05
L01BB02
L01BB07
L01BB03
Pyrimidine analogues
L01BC01
L01BC05

Reference

  1. Almirall Hermal, SmPC Verrumal®, Lösung zur Anwendung auf der Haut (244.00.00), 07/2020

Changes

Therapeutic Drug Monitoring


Overdose